NDC 83854-002-01 - LACOSAMIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 83854-002
- Requested NDC
- 83854-002-01
- Package NDCs from labels
- 83854-002-01, 83854-002-10
- Manufacturer
- Anthea Pharma Private Limited
- Effective date
- 2026-01-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACOSAMIDE - Anthea Pharma Private Limited | Anthea Pharma Private Limited | 2026-01-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 83854-002-01 | LACOSAMIDE | 20 mL in 1 VIAL | INJECTION, SOLUTION | 20 | 5 | |
| 83854-002-10 | LACOSAMIDE | 10 in 1 CARTON | INJECTION, SOLUTION | 10 | 5 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LACOSAMIDE | LACOSAMIDE | Precision Dose, Inc. | fe24b28b-ca15-4dfd-a198-53cdc2c8cb99 | 2025-03-31 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | American Health Packaging | f9aa6154-5d80-4597-90c3-cec131b455d4 | 2025-03-26 | Warnings, Adverse reactions | 563KS2PQY5 |
| LACOSAMIDE | LACOSAMIDE | Coupler LLC | 2d999f1f-11c6-bc28-e063-6394a90a4a52 | 2025-02-20 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide Oral Solution | LACOSAMIDE | Chartwell RX, LLC | 7197c0b6-5bb9-43b3-be1d-e7615629df9a | 2025-02-12 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Florida Pharmaceutical Products, LLC | 3680c0ff-7f5c-4572-b1eb-4fea96b7fbe2 | 2025-02-12 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Fresenius Kabi USA, LLC | 419ff519-2b19-4fb9-adfa-868ba0229407 | 2025-02-05 | Warnings, Adverse reactions | 809974 563KS2PQY5 |
| LACOSAMIDE | LACOSAMIDE | Golden State Medical Supply, Inc. | f047077c-2ac7-30d0-e053-2995a90ae429 | 2025-01-27 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Novadoz Pharmaceuticals LLC | a024081a-e131-4e88-967d-40155651a945 | 2024-12-31 | Warnings, Adverse reactions | 809974 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Marlex Pharmaceuticals, Inc | 0a273024-c2d2-4fae-90c3-b2f38a323f24 | 2024-12-15 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Leading Pharma, LLC | 45786c84-51ef-4440-bc88-2501951e4c41 | 2024-12-06 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Trigen Laboratories, LLC | d98ec7ed-353f-4d4f-9ccd-57ddc62edd0d | 2024-11-20 | Warnings, Adverse reactions | 809974 563KS2PQY5 |
| LACOSAMIDE | LACOSAMIDE | Somerset Therapeutics, LLC | 00203a7b-e774-45f7-ac6b-48db6d32a48a | 2024-10-16 | Warnings, Adverse reactions | 809974 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Sun Pharmaceutical Industries, Inc. | 2098d3a5-776e-4b52-8ade-80a3ab7b3de7 | 2024-10-14 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Unichem Pharmaceuticals (USA), Inc. | 7ed5cebe-470e-48a4-86ec-2ce79cc32688 | 2024-09-17 | Warnings, Adverse reactions | 563KS2PQY5 |
| LACOSAMIDE | LACOSAMIDE | Breckenridge Pharmaceutical, Inc. | f7ea3ce6-4ca7-4405-a011-48e7d71360a5 | 2024-09-12 | Warnings, Adverse reactions | 563KS2PQY5 |
| LACOSAMIDE | LACOSAMIDE | NorthStar RxLLC | e969b294-48d9-42a2-a093-0ac715142460 | 2024-08-05 | Warnings, Adverse reactions | 809974 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Major Pharmaceuticals | 973cea8d-e516-4014-a116-c5990554a550 | 2024-07-22 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Macleods Pharmaceuticals Limited | 035d85e5-8688-4390-bd55-74baa91c0e9d | 2024-06-04 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | PAI Holdings, LLC dba PAI Pharma | 75de00d8-d2e7-4025-be4e-f49299068e7e | 2024-05-30 | Warnings, Adverse reactions | 563KS2PQY5 |
| Lacosamide | LACOSAMIDE | Amneal Pharmaceuticals of New York LLC | 0e21389b-2f51-4975-aa21-fc5c9dd9f6dc | 2024-05-17 | Warnings, Adverse reactions | 563KS2PQY5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.